Home News Discover the latest breakthroughs, stories, and updates from Oncode Institute’s mission to outsmart cancer. Search Category Category Blog Post External Events Research news Our Team press news In Memoriam: Corien de Vries 17 Oct 2024 Bridging the Gap: Researchers and Patients Unite in an Inspirational Lecture 10 Sep 2024 Menstrual cycle influences the spread of mutant cells in mammary tissue 4 Sep 2024 Highlights of the Oncode Institute Annual Meeting 2024 1 Jul 2024 Cancer research and our unique story featured in the new podcast episode of Leaders in Life Sciences 25 Jun 2024 A key to effective cancer immunotherapy 20 Jun 2024 Research on centromere structure yields new insights into the mechanisms of chromosome segregation errors 6 Jun 2024 New findings pave the way for development of new therapies for incurable acute myeloid leukemia (AML) 5 Jun 2024 Deepening understanding of early mammalian embryogenesis 15 May 2024 Oncode Researchers Discover New Pathway to Cancer Cell Suicide 15 May 2024 Oncode Oncology Bridge Fund portfolio company Flindr Therapeutics announces €20 million Series A financing 26 Apr 2024 Flindr Therapeutics (previously Immagene) closes 20 million Series A financing 24 Apr 2024 Three Oncode Investigators awarded competitive ERC Advanced grant 10 Apr 2024 Bacteria in cancer unmasked 8 Apr 2024 Researchers discover a new transcription-coupled repair mechanism 3 Apr 2024 Beating by overheating: Oncode researchers lead study into new strategy to combat cancer 27 Mar 2024 Pagination Previous page ‹ … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page ›
Cancer research and our unique story featured in the new podcast episode of Leaders in Life Sciences 25 Jun 2024
Research on centromere structure yields new insights into the mechanisms of chromosome segregation errors 6 Jun 2024
New findings pave the way for development of new therapies for incurable acute myeloid leukemia (AML) 5 Jun 2024
Oncode Oncology Bridge Fund portfolio company Flindr Therapeutics announces €20 million Series A financing 26 Apr 2024
